2197
Clover Biopharmaceuticals is a global commercial-stage biopharmaceutical company focused on the discovery, development, and delivery of innovative vaccines to improve health worldwide. The company emphasizes its Trimer-Tag technology and in-house manufacturing capabilities to advance vaccine candidates and address infectious diseases. With global partnerships and a commitment to affordable solutions, Clover operates across international markets and clinical development programs. The organization is headquartered in a setting that highlights its global reach and leadership in vaccine science.
No recent news for this company.
No recent deals for this company.